First Horizon Advisors, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.28 Billion
- Q2 2024
A detailed history of First Horizon Advisors, Inc. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 30,398 shares of DNA stock, worth $207,010. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,398
Previous 32,649
6.89%
Holding current value
$207,010
Previous $37,000
72.97%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding DNA
# of Institutions
347Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$974 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$946 Million0.0% of portfolio
-
Baillie Gifford & CO134MShares$915 Million0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$476 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$286 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $8.77B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...